Task Group Charge
To identify imaging technology needs and potential solutions (e.g., hardware, software or interoperability methods or procedures), and strategies to further their use and transition into all clinical points along the multi-disciplinary care pathway of lung cancer including lung cancer screening, early detection, diagnosis and management.
Leadership
Daniel C. Sullivan, MD
Task Group Chair
Duke Cancer Institute
Michael McNitt-Gray, PhD
Task Group Vice Chair
University of California, Los Angeles
Task Group Members
Denise Aberle, MD
University of California, Los Angeles (UCLA)
Samuel Armato, PhD
University of Chicago
Rick Avila, MS
Accumetra
Paul Bergstrom, PhD
National Institute of Standards and Technology
Maria Chong, PhD
RADIA Imaging (Seattle, Washington)
Dianna Cody, PhD
The University of Texas MD Anderson Cancer Center
Laura Coombs, PhD
American College of Radiology Data Science Institute
Richard Frank, MD, PhD
Siemens Healthineers North America
Robert Gillies, PhD
Moffitt Cancer Center
Jonathan Goldin, MD, PhD
UCLA
Jayashree Kalpathy-Cramer, PhD
Athinoula A. Martinos Center for Biomedical Imaging
Ella Kazerooni, MD, MS*
University of Michigan
Nicholas Petrick, PhD
FDA
David Yankelevitz, MD
Icahn School of Medicine at Mt. Sinai
(*) indicates Steering Committee member
Opportunities for Intervention/Influence:
- Foster advances in imaging technology to improve sensitivity and specificity of cancer detection in lung cancer screened individuals
- Improve protocols for screening and follow-up
- Promote quality imaging facilities and providers